Nephrogen Alternatives & Competitors
12 companies similar to Nephrogen — Curative gene therapies for kidney diseases
Companies similar to Nephrogen
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
London, United Kingdom
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Rival Readout
Competing with Nephrogen? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Apertura Gene Therapy
Bringing the Future of Gene Therapy into Focus
New York, United States
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Cambridge, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Jasper Therapeutics
Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...
Redwood City, United Stat...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
THRASOS LIMITED
Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...
About Nephrogen
Nephrogen, founded in 2022, is a burgeoning player in the biotechnology and health care industries, with a mission conveyed succinctly through its slogan: "Curative gene therapies for kidney diseases." This United States-based company is pioneering efforts to address unmet medical needs, namely focusing initially on po...
Development of curative genomic medicines, AI-driven gene delivery platform, High-throughput in vivo screening, Research and development in gene therapy
Patients with kidney and pancreatic diseases, Medical professionals in nephrology, Biotech and pharmaceutical companies, Healthcare providers
Biotech, Gene Therapy, Kidney Diseases, Polycystic Kidney Disease, PKD Treatment, Curative Therapies, Biopharmaceuticals, Genomic Medicine, Disease-specific Therapy, Therapeutic Development, Medical Research, Clinical Biotechnology
B2B, B2B2C, Platform
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Nephrogen: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Nephrogen on 7 Apr 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
